Cellectis Income Statement (2014-2023) | CLLS

Income Statement Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023
Revenue & cost
Revenue 9.52M8.10M8.45M29.59M7.70M20.50M11.27M8.20M6.74M6.49M6.12M5.72M6.04M5.05M0.91M0.97M1.04M1.15M8.49M4.42M50.13M2.90M6.18M13.65M25.60M11.18M8.31M10.26M1.67M1.31M0.17M16.02M0.14M0.18M0.15M
Cost of Revenue 0.48M0.43M0.37M1.45M0.48M0.33M0.35M0.62M0.61M0.56M0.57M0.88M0.58M0.56M0.87M0.72M0.59M0.81M4.26M5.65M4.60M5.83M7.82M18.64M8.14M11.75M9.21M0.24M0.39M0.33M0.37M0.69M0.33M0.06M0.18M
Gross Profit 9.04M7.67M8.08M28.14M7.22M20.17M10.92M7.59M6.13M8.40M5.55M4.84M5.46M4.49M0.04M0.25M0.45M0.34M4.23M-1.23M45.53M-2.93M-1.64M-5.00M17.46M-0.58M-0.90M-0.07M1.28M0.98M-0.19M15.33M-0.20M0.12M-0.03M
Operating items
Research & Development -8.40M-14.13M-17.97M-17.58M-20.81M-22.06M-15.43M-20.15M-19.58M-18.61M-20.29M-20.70M-18.39M-18.04M-18.69M-21.27M-14.51M-25.42M-21.60M-30.32M-20.72M-22.86M-20.10M23.39M-31.00M-31.15M-34.32M-29.54M-26.60M-25.63M-23.84M-21.43M-21.41M-22.20M-19.07M
Selling, General & Administrative -6.05M-7.59M-7.70M-8.87M-11.61M-9.72M-9.73M-12.29M-9.73M-10.02M-12.15M-12.99M-14.01M-11.25M-11.56M-10.52M-11.49M-11.82M-10.97M-8.77M-12.15M-9.07M-10.30M12.49M-8.78M-9.34M-9.68M-6.51M-6.06M-4.83M-4.90M-1.70M-4.96M-3.95M-3.23M
Other Operating Expenses -4.22M-0.08M0.29M-0.01M-0.28M-0.10M0.37M0.05M-0.09M0.02M-0.19M0.03M0.16M0.03M-0.00M-0.04M-0.08M-0.03M0.11M-0.37M0.27M0.06M0.15M0.02M0.01M0.02M0.75M-0.12M0.84M-0.61M0.53M-0.01M
Operating Expenses -14.46M-21.71M-25.67M-30.67M-32.99M-31.82M-25.52M-33.34M-30.03M-28.82M-32.96M-34.67M-32.97M-30.04M-31.10M-32.34M-26.55M-38.06M-36.86M-44.83M-37.49M-37.65M-38.59M54.80M-47.87M-52.10M-53.20M-36.28M-33.03M-30.04M-29.23M-22.98M-26.99M-25.62M-22.31M
Operating Income -4.02M-13.40M-14.96M1.32M-22.51M-11.32M-12.90M-20.32M-19.75M-19.85M-25.70M-27.76M-24.90M-21.70M-28.90M-29.27M-23.12M-35.13M-26.65M-38.49M14.41M-33.03M-29.35M-39.16M-19.91M-37.48M-42.37M-24.56M-29.23M-27.31M-27.35M-5.66M-23.43M-23.62M-20.67M
EBIT -4.02M-13.40M-14.96M1.32M-22.51M-11.32M-12.90M-20.34M-19.76M-19.84M-25.70M-27.76M-24.90M-21.70M-28.90M-29.27M-23.12M-35.13M-26.65M-38.49M14.41M-33.03M-29.35M-39.16M-19.91M-37.48M-42.37M-7.68M-29.23M-27.31M-27.35M-5.66M-23.43M-23.62M-20.67M
Non-operating items
Interest & Investment Income 2.27M9.99M2.90M-6.28M0.78M10.44M4.92M
Other Non Operating Income 0.14M-15.04M12.92M-0.13M-0.26M-0.21M-0.08M0.10M0.16M
Non Operating Income 11.16M-11.09M0.76M7.71M-9.99M4.25M-1.16M6.87M-0.02M-6.65M-3.39M-0.96M-2.14M11.96M3.59M3.20M5.40M-1.51M7.17M-2.66M2.19M-2.82M-4.25M7.57M4.56M-4.13M2.30M3.13M0.91M8.30M1.81M-19.95M-4.40M-5.84M3.29M
Net income details
EBT -4.02M-13.40M-14.96M1.32M-22.51M-11.32M-12.90M-20.34M-19.76M-19.84M-25.70M-27.76M-24.90M-21.70M-28.90M-29.27M-23.12M-35.13M-26.65M-38.49M14.41M-33.03M-29.35M-39.16M-19.91M-37.48M-42.37M-8.07M-25.60M-15.63M-23.37M-11.94M-17.48M3.10M-14.13M
Profit After Tax 0.02M7.14M-24.50M-14.20M9.03M-32.50M-7.07M-14.06M-13.45M-19.77M-26.50M-29.10M-28.72M-25.44M-32.42M-55.42M-26.07M-15.25M-48.79M-64.70M-41.16M20.08M-35.85M-41.60M46.73M-15.35M-51.79M-89.20M-28.08M-31.91M-50.86M-79.33M-28.56M-30.07M-16.64M-58.20M
Income from Non-Controlling Interests 0.19M-2.94M-1.55M-1.60M-2.48M-2.51M-2.99M-2.48M-3.19M-3.48M-3.95M-3.48M-3.59M-3.31M-6.12M-3.48M-1.69M-2.66M-3.08M-2.85M0.51M-2.80M-1.74M-2.45M-4.93M
Income from Continuing Operations -4.02M-13.40M-14.96M1.32M-22.51M-11.32M-12.90M-20.34M-19.76M-19.84M-25.70M-27.76M-24.90M-21.70M-28.90M-29.27M-23.12M-35.13M-26.65M-38.49M14.41M-33.03M-29.35M-39.16M-19.91M-37.48M-42.37M-8.07M-25.60M-15.63M-23.37M-11.94M-17.48M3.10M-14.13M
Consolidated Net Income -4.02M-13.40M-22.51M-11.32M-12.90M-20.34M-19.76M-19.84M-25.70M-27.76M-24.90M-21.70M-28.90M-29.27M-23.12M-35.13M-26.65M-38.49M14.41M-33.03M-29.35M-39.16M-37.48M-42.37M-6.65M-6.44M-0.44M-5.72M-2.86M-4.69M13.08M
Income towards Parent Company 6.94M-24.50M-14.20M9.03M-32.50M-7.07M-14.06M-13.45M-19.77M-26.50M-26.15M-27.17M-25.44M-7.26M-22.80M-23.07M-15.25M-33.45M-16.00M-37.21M20.08M-32.26M-30.30M-40.61M-11.87M-39.92M-37.41M-25.00M-31.91M-18.95M-28.47M-26.82M-30.07M-11.71M-17.48M
Net Income towards Common Stockholders 6.94M-24.50M-14.20M9.03M-32.50M-7.07M-14.05M-13.46M-19.78M-26.48M-26.15M-27.17M-25.44M-7.26M-22.80M-23.07M-15.25M-33.45M-16.00M-37.21M20.08M-32.26M-30.30M-40.61M-39.92M-37.41M-8.07M-18.95M-28.47M-26.82M-30.07M-11.71M-17.48M
Additional items
EPS (Basic) -29.0842.73-42.45-34.12-0.18-0.42-72.47-15.01
EPS (Weighted Average and Diluted) 26.72-29.08-42.45-34.12
Shares Outstanding (Weighted Average) 1.15M0.47M0.76M1.17M43.79M45.50M0.37M0.78M
Shares Outstanding (Diluted Average) 0.26M1.15M0.76M1.17M
EBITDA -4.02M-13.40M-14.96M1.32M-22.51M-11.32M-12.90M-20.34M-19.76M-19.84M-25.70M-27.76M-24.90M-21.70M-28.90M-29.27M-23.12M-35.13M-26.65M-38.49M14.41M-33.03M-29.35M-39.16M-19.91M-37.48M-42.37M-7.68M-29.23M-27.31M-27.35M-5.66M-23.43M-23.62M-20.67M
Interest Expenses -1.36M-1.69M-1.09M-5.18M-16.28M-1.62M